Some investors might have been disappointed by Cresco's Q2 results. However, they really weren't all that bad considering those macro headwinds Bachtell referenced. The company's Q2 revenue of $218 ...
CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), a vertically integrated multistate operator and the No. 1 U.S. wholesaler of branded cannabis products, today ...
Cresco Labs (OTC: CRLBF) is one of the leading companies in the marijuana industry. However, the share price of the multi-state operator has crashed by 75% over the past 12 months as the excitement ...
Based on the one-year price targets offered by 8 analysts, the average target price for Cresco Labs Inc (XCNQ:CL) is $2.57, with a high estimate of $3.26 and a low estimate of $1.75. The average ...
Cresco Labs Q1 results show higher adjusted EBITDA and improved financial performance despite a decline in revenue. Analysts have raised their outlook for Cresco Labs, projecting revenue growth in ...
Based on the one-year price targets offered by 8 analysts, the average target price for Cresco Labs Inc (XCNQ:CL) is $4.37 with a high estimate of $6 and a low estimate of $2.5. The average target ...
Upon acquisition of Columbia Care, Cresco Labs will have presence in 18 states, becoming one of the largest if not the largest multi-state operator. Facing fierce competition, revenue has been ...
CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis ...
Cresco Labs Inc. said Wednesday it has agreed to acquire Columbia Care Inc. for $2 billion in stock. Columbia Care shareholders will receive 0.5579 of a subordinate voting share of Cresco Labs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results